Euphoria enters capital and business alliance with Sysmex, global leader in clinical testing
Sports tech company Euphoria and clinical testing leader Sysmex have announced a capital and business alliance to integrate biological and behavioral data, aiming to develop new health and sports solutions.
📋 Article Processing Timeline
- 📰 Published: April 13, 2026 at 20:11
- 🔍 Collected: April 13, 2026 at 16:35
- 🤖 AI Analyzed: April 19, 2026 at 20:19 (147h 44m after Collected)
Sports tech company EUPHORIA Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo, Representative Directors: Makoto Miyata, Hiroshi Hashiguchi, hereinafter 'Euphoria') has entered into a capital and business alliance with Sysmex Corporation (Headquarters: Kobe City, Hyogo Prefecture, President: Iwane Matsui, hereinafter 'Sysmex') in the healthcare and sports domains.
Moving forward, both companies will integrate their respective assets to strongly promote health improvement through the integration of biological data and behavioral data based on sports medicine and science, as well as the development and social implementation of new solutions.
■ Background and Aim: Optimizing the 'Healthcare Journey' through Data Integration
In recent years, the importance of data-driven condition management has increased in the sports field and corporate health management. However, daily 'behavioral/exercise data' and highly reliable 'biological data (test data)' obtained at medical institutions are often fragmented, creating a challenge in comprehensively evaluating an individual's state and linking it to accurate decision-making and behavioral change.
Through its condition management system 'ONE TAP SPORTS', Euphoria has supported the performance improvement of many athletes. Recently, it has expanded this expertise into health management support services for corporate employees, leading the accumulation and utilization of daily health data.
On the other hand, Sysmex possesses advanced testing technology and analytical expertise as a leading company in the clinical testing domain. The company champions the optimization of the 'Healthcare Journey' [*1] that supports each individual's lifelong path of health, and is driving business expansion into health promotion and sports domains utilizing POCT (Point-of-Care Testing) [*2]. This alliance aims to seamlessly connect the previously fragmented 'internal state of the body' and 'daily activities', striving to realize a society where not only athletes but also the general public can maximize their potential.
■ Co-creation Initiatives by Both Companies
Keeping a broad perspective from the sports domain to the general wellness domain, both companies will promote the following initiatives.
1. Creation of new value standards and construction of evaluation models through joint research
We will conduct joint research and empirical experiments on the correlation between biological data and performance/health status, creating new value standards that fuse sports medicine/science with medical care. Concurrently, we will construct evaluation models by competition type and domain, establishing methods to objectively visualize and evaluate individual conditions.
2. Solution development through linkage with 'ONE TAP SPORTS' and promotion in the sports world
By linking Euphoria's data platform 'ONE TAP SPORTS' with Sysmex's POCT devices, we will drive the development of concrete solutions through empirical experiments. We aim to socially implement a system where consumers and athletes can understand their status based on scientific evidence and proactively improve their behavior, while promoting its widespread adoption across the sports world.
3. Consideration of future AI utilization
We are also keeping the future utilization of accumulated data analysis and Euphoria's proprietary multi-agent AI 'QUARIA AI' [*3] in our prospects. Through this, we will consider providing more personalized health experiences, such as the automatic generation of optimal advice tailored to an individual's condition.
Under the strong partnership formed by this alliance, both companies will contribute to the realization of 'a society where sports medicine/science and medical care are seamlessly connected' and 'a future where everyone can achieve their unique health status and best performance'.
[Notes]
*1 Healthcare Journey: Each individual's lifelong healthcare path. It is a registered trademark of Sysmex Corporation.
*2 POCT (Point-of-Care Testing): A testing method that allows test results to be obtained quickly outside medical institutions or on the spot.
*3 QUARIA AI: An AI technology developed by Euphoria that optimizes the knowledge and data of sports medicine/science to analyze and support individual performance and health status.
■ About Sysmex Corporation
Under its group corporate philosophy 'Sysmex Way', Sysmex has set its mission to 'Shaping the advancement of healthcare.' Since its founding in 1968, the company has developed its business centering on the clinical testing field, which involves collecting and examining blood, urine, etc., and currently supports people's health in over 190 countries and regions. We aim to realize a better healthcare journey.
Moving forward, both companies will integrate their respective assets to strongly promote health improvement through the integration of biological data and behavioral data based on sports medicine and science, as well as the development and social implementation of new solutions.
■ Background and Aim: Optimizing the 'Healthcare Journey' through Data Integration
In recent years, the importance of data-driven condition management has increased in the sports field and corporate health management. However, daily 'behavioral/exercise data' and highly reliable 'biological data (test data)' obtained at medical institutions are often fragmented, creating a challenge in comprehensively evaluating an individual's state and linking it to accurate decision-making and behavioral change.
Through its condition management system 'ONE TAP SPORTS', Euphoria has supported the performance improvement of many athletes. Recently, it has expanded this expertise into health management support services for corporate employees, leading the accumulation and utilization of daily health data.
On the other hand, Sysmex possesses advanced testing technology and analytical expertise as a leading company in the clinical testing domain. The company champions the optimization of the 'Healthcare Journey' [*1] that supports each individual's lifelong path of health, and is driving business expansion into health promotion and sports domains utilizing POCT (Point-of-Care Testing) [*2]. This alliance aims to seamlessly connect the previously fragmented 'internal state of the body' and 'daily activities', striving to realize a society where not only athletes but also the general public can maximize their potential.
■ Co-creation Initiatives by Both Companies
Keeping a broad perspective from the sports domain to the general wellness domain, both companies will promote the following initiatives.
1. Creation of new value standards and construction of evaluation models through joint research
We will conduct joint research and empirical experiments on the correlation between biological data and performance/health status, creating new value standards that fuse sports medicine/science with medical care. Concurrently, we will construct evaluation models by competition type and domain, establishing methods to objectively visualize and evaluate individual conditions.
2. Solution development through linkage with 'ONE TAP SPORTS' and promotion in the sports world
By linking Euphoria's data platform 'ONE TAP SPORTS' with Sysmex's POCT devices, we will drive the development of concrete solutions through empirical experiments. We aim to socially implement a system where consumers and athletes can understand their status based on scientific evidence and proactively improve their behavior, while promoting its widespread adoption across the sports world.
3. Consideration of future AI utilization
We are also keeping the future utilization of accumulated data analysis and Euphoria's proprietary multi-agent AI 'QUARIA AI' [*3] in our prospects. Through this, we will consider providing more personalized health experiences, such as the automatic generation of optimal advice tailored to an individual's condition.
Under the strong partnership formed by this alliance, both companies will contribute to the realization of 'a society where sports medicine/science and medical care are seamlessly connected' and 'a future where everyone can achieve their unique health status and best performance'.
[Notes]
*1 Healthcare Journey: Each individual's lifelong healthcare path. It is a registered trademark of Sysmex Corporation.
*2 POCT (Point-of-Care Testing): A testing method that allows test results to be obtained quickly outside medical institutions or on the spot.
*3 QUARIA AI: An AI technology developed by Euphoria that optimizes the knowledge and data of sports medicine/science to analyze and support individual performance and health status.
■ About Sysmex Corporation
Under its group corporate philosophy 'Sysmex Way', Sysmex has set its mission to 'Shaping the advancement of healthcare.' Since its founding in 1968, the company has developed its business centering on the clinical testing field, which involves collecting and examining blood, urine, etc., and currently supports people's health in over 190 countries and regions. We aim to realize a better healthcare journey.